Dengue overview: An updated systemic review

J Infect Public Health. 2023 Oct;16(10):1625-1642. doi: 10.1016/j.jiph.2023.08.001. Epub 2023 Aug 3.

Abstract

Dengue is caused by the dengue virus (DENVs) infection and clinical manifestations include dengue fever (DF), dengue hemorrhagic fever (DHF), or dengue shock syndrome (DSS). Due to a lack of antiviral drugs and effective vaccines, several therapeutic and control strategies have been proposed. A systemic literature review was conducted according to PRISMA guidelines to select proper references to give an overview of DENV infection. Results indicate that understanding the virus characteristics and epidemiology are essential to gain the basic and clinical knowledge as well as dengue disseminated pattern and status. Different factors and mechanisms are thought to be involved in the presentation of DHF and DSS, including antibody-dependent enhancement, immune dysregulation, viral virulence, host genetic susceptibility, and preexisting dengue antibodies. This study suggests that dissecting pathogenesis and risk factors as well as developing different types of therapeutic and control strategies against DENV infection are urgently needed.

Keywords: Dengue fever; Dengue hemorrhagic fever; Dengue shock syndrome; Dengue virus; PRISMA; Systemic review.

Publication types

  • Systematic Review

MeSH terms

  • Antiviral Agents* / therapeutic use
  • Dengue* / epidemiology
  • Dengue* / therapy
  • Genetic Predisposition to Disease
  • Humans
  • Risk Factors
  • Virulence

Substances

  • Antiviral Agents